The U.S. federal government is seeking input from the American public ahead of a meeting with the U.N. agency, the World Health Organization (WHO), to discuss medical pot.
The federal agency, the U.S. Food and Drug Administration (FDA), said on Monday that it is asking “interested persons” to pitch in their concerns over the “abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on availability for medical use of five drug substances.”
The feedback gleaned from the public will be used in preparing the Trump administration’s response to the WHO “regarding the abuse liability and diversion” of medical marijuana, according to a version of the notice added to the Federal Register’s website and first reported by Forbes on Friday.
“WHO will use this information to consider whether to recommend that certain international restrictions be placed,” the notice said.
The WHO’s Expert Committee on Drug Dependence (ECDD) are scheduled to meet wth the FDA in early June in Geneva, according to the notice.
ECDD pre-reviewed CBD, the non-psychoactive component in cannabis, last year. It found to be have medical benefits, and recommended that it be subject to further analysis, Forbes reported.